1991
DOI: 10.1021/jm00105a050
|View full text |Cite
|
Sign up to set email alerts
|

Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents

Abstract: A series of dihydrobenzofuran and dihydrobenzopyran thiazolidine-2,4-diones (compounds 3-26) was synthesized from the corresponding aryl aldehydes 1 in two steps. These compounds represent conformationally restricted analogues of the novel hypoglycemic ciglitazone. The series was evaluated by hypoglycemic effects in vitro by measuring stimulation of 2-deoxyglucose uptake in L6 myocytes and stimulation of expression of the glucose transporter protein in 3T3-L1 adipocytes. In vivo hypoglycemic effects were evalu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
30
0

Year Published

1997
1997
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(31 citation statements)
references
References 2 publications
1
30
0
Order By: Relevance
“…metformin) [90]. Recently, a new class of antidiabetic agents, the thiazolidinediones, has been developed and clinically evaluated [91, 92]. As a class, thiazolidinediones have been shown to enhance peripheral insulin sensitivity in animal models of insulin resistance [93, 94]and type II diabetic patients [95].…”
Section: Can Diabetes Be Treated?mentioning
confidence: 99%
“…metformin) [90]. Recently, a new class of antidiabetic agents, the thiazolidinediones, has been developed and clinically evaluated [91, 92]. As a class, thiazolidinediones have been shown to enhance peripheral insulin sensitivity in animal models of insulin resistance [93, 94]and type II diabetic patients [95].…”
Section: Can Diabetes Be Treated?mentioning
confidence: 99%
“…Further, in vivo oral hypoglycemic activity of selected compounds of this series were further evaluated in genetically obese ob/ob mouse. On the basis of in vivo potency as well as additional profiling in alternative animal models, to resolved dihydrobenzopyran containing englitazone (8) was selected for clinical trial study 31 shows more potent activity in adipocytes differentiation assay and good hypoglycemic activity. In addition, hydrochloric salt of (11) was prepared and selected as a testing candidate over rosiglitazone (4) for a clinical study.…”
Section: 30mentioning
confidence: 99%
“…▪ Inclusion of central phenoxyalkyl linker (B) into a different heterocyclic rings are also leads to active thiazolidine-2,4-diones, which are including englitazone (8) 31 , T-174 (22) 52 and edaglitazone (25) 56 . ▪ Replacement of central phenoxyalkyl linker (B) by naphthalene ring to give netoglitazone (14) compound of thiazolidine-2,4-diones class, which show more potent activity, as compared to rosiglitazone (4) 44 .…”
mentioning
confidence: 99%
“…[49][50][51][52][53][54][55] In 2002, Grigg and co-workers reported an interesting Pd-catalyzed queuing processes by employing allene as a relay switch and secondary amines as nucleophiles. 39 Inspired by these precedents and our continued interest in the palladium-catalyzed cross-coupling of N-tosylhydrazones, [56][57][58][59] we conceived that the alkyl-Pd species generated from intramolecular carbopalladation of alkene may be trapped by a diazo substrate to form a Pd carbene species, which would undergo migratory insertion and β-hydride elimination to afford the polysubstituted olefins (Scheme 1c).…”
Section: Introductionmentioning
confidence: 99%